Reshaping patient care with efficiency and humanity.

Biologics empowers healthcare providers, payers and manufacturers to deliver oncology, neurology and other complex care needs for the best possible patient outcomes – clinical, financial and emotional. Setting the standard for “high-touch” in the specialty pharmacy market, our team provides innovative solutions to our healthcare practices and ultimately helps supports patients on their path to better health.

Learn more

Contain your costs while improving outcomes. Integrative cancer care makes it possible.

When it comes to oncology care, payers face two challenges: managing risk and ensuring better outcomes across the cancer care continuum. We show you how meeting one goal helps achieve the other — and that you don’t have to take on either alone.

Find out how

Broader market access begins with integration.

From launch strategies to adherence programs to outcome reporting, we work with you to reach your goals for your drugs. Our custom solutions enhance patient access, and our care management models encourage patients to stay on therapy. It’s all part of our integrative cancer care approach.

Find out how

For your oncology trial, success is in the details.

Cancer therapeutics are as complex as the diseases they treat, but we can make clinical studies simpler. When you trust us to manage the details, from patient kit logistics and distribution to outcome reporting, you can concentrate on the science. We take care of everything else.

Find out how

We free clinicians to focus on the fight.

We specialize in cancer care alignment, synchronizing services so you and your patients can concentrate on treatment instead of logistics. We’re working on your patient’s behalf at every point in the cancer care continuum — so you know nothing will slip through the cracks.

Find out how

XOSPATA (gilteritinib) Available for Order at Biologics by McKesson

XOSPATA is FDA Approved for Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation CARY, N.C., December XX, 2018 — Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, announced that it has been selected by Astellas Pharma US, Inc. to be in t …

Read more